>>>>>>It's OT because it doesn't add to the debate
rruff,
Ah, so you view MCOM's performance as a "debate". The debate is over, votes have been counted and MCOM by it's performance, has lost the confidence of investor's, both large and small.
No, I will honestly tell you I take no pleasure making profits shorting while other's are being hurt.
I will tell you now I am not shorting MCOM from it's extremely oversold position, yet in the short term, I think it will see $7 before it see's $13.
Furthermore, I won't come on to say what is obvious if the stock is down.
>>>>>>>If that's the best you can do when you come up for air, that's great. Is that your profession?<<<<<<<<<<<<<
Debating the obvious is not my profession. Doing research on the cause of myopia in the hopes of finding a cure for millions of people around the world, at the Wilmer Eye Institute is. As I probably won't make new posts here, I would like to encourage you to contribute (tax-deductable), what you can to:
Wilmer Eye Institute c/o Dr. Morton Goldberg, Director MIRF Foundation (Myopia Int'l Research Foundation) 600 North Wolfe St. Baltimore, MD 21287
I wanted to gauge the amount of support MCOM had on this thread by those who have done more extensive DD on it. As there is a vibrant defense of the stock, by obviously intelligent people, i would hesitate shorting it. I wish you good luck.
Regards, S. Kratcher, M.D. |